ESC 365 - Direct oral anticoagulants versus vitamin K antagonists as stroke prevention in atrial fibrillation after cardiac surgery: a systematic review and meta-analysis

EHRA Premium Access

Direct oral anticoagulants versus vitamin K antagonists as stroke prevention in atrial fibrillation after cardiac surgery: a systematic review and meta-analysis

Session: Atrial fibrillation: stroke - oral anticoagulants

Topic: Oral Anticoagulation

Speaker: Mr M. Terpstra (Amsterdam, NL)

Event: EHRA 2024

Congress Presentation

Add to my library

About the speaker

Mr Marc Terpstra

Amsterdam (Netherlands (The))

0 follower

5 more presentations in this session

Genetic and clinical risk factors for stroke recurrence with different impact by assessment age: data from the UK Biobank

Speaker: Doctor S. Chung (Seoul, KR)

Characteristics and incidence of peri-device leaks after left atrial appendage closure in patients with prior electrical isolation of left atrial appendage during catheter ablation

Speaker: Doctor A. Maan (New York, US)

Predicting atrial fibrillation risk following embolic stroke of unknown source using cardiac magnetic resonance imaging

Speaker: Doctor I. Kotadia (London, GB)

Clinical impact of renal function changes in patients with atrial fibrillation receiving anticoagulation with marginal renal function

Speaker: Doctor K. Lee (Seoul, KR)

Impact of photoplethysmography-based smartphone rhythm monitoring on atrial fibrillation detection and management after cardiac surgery: a pragmatic randomized trial

Speaker: Doctor H. Gruwez (Genk, BE)

Access the full session

Atrial fibrillation: stroke - oral anticoagulants

Speakers: Mr M. Terpstra, Doctor S. Chung, Doctor A. Maan, Doctor I. Kotadia, Doctor K. Lee...

About the event

EHRA 2024

7 April - 9 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources